Real World Evidence: ‘Hot Topic’ At US FDA, But Not On Front Burner

Officials are enthusiastic about the possibility of ‘real world evidence’ supporting the regulatory process – but are also eager to tamp down expectations (or fears) that it will make a big difference any time soon.